Lv6
1880 积分 2021-05-19 加入
Effects of nerandomilast, a preferential PDE4B inhibitor, on metabolism of midazolam, a sensitive CYP3A substrate
2个月前
已关闭
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
5个月前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
5个月前
已完结
Interstitial Lung Disease
6个月前
已完结
Mechanisms and regulation of endothelial VEGF receptor signalling
6个月前
已完结
Biology and therapeutic targeting of vascular endothelial growth factor A
6个月前
已完结
Diabetic macular edema: Upcoming therapies
9个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
11个月前
已完结
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration
1年前
已完结
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
1年前
已完结
Sensitivity of PET/MR images in liver metastases from colorectal carcinoma
皖公网安备34019202002308
